ARTICLES BY RAJENDRAN (RAJ) ARUNAGIRI
-
3 Action Items For The US Bio/Pharma Industry To Mitigate Supply Vulnerabilities6/12/2023
The United States’ reliance on foreign manufacturers of API has been a known fact for several years. We can mitigate our supply vulnerabilities, but bio/pharma companies and the FDA both have roles to fill in this need.
This website uses cookies to ensure you get the best experience on our website. Learn more